Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

Gregory T. Everson, Karen D. Sims, Paul J. Thuluvath, Eric Lawitz, Tarek Hassanein, Maribel Rodriguez-Torres, Tadesse Desta, Trevor Hawkins, James M. Levin, Federico Hinestrosa, Vinod Rustgi, Howard Schwartz, Zobair Younossi, Lynn Webster, Norman Gitlin, Timothy Eley, Shu Pang Huang, Fiona Mcphee, Dennis M. Grasela, David F. Gardiner

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences